The Molecular Basis of Memantine Action in Alzheimer's Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|2|2|155-165

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.2, Iss.2, 2005-04, pp. : 155-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease

By Capsoni Simona   Cattaneo Antonino  

Cellular and Molecular Neurobiology, Vol. 26, Iss. 4-6, 2006-07 ,pp. : 617-631

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer's Disease and Related Disorders Annual.

By Hachinski V.  

Brain, Vol. 124, Iss. 3, 2001-03 ,pp. : 638-639

Oxford University Press

Access to resources Recommend Favorite

N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

By  

Current Alzheimer Research, Vol. 9, Iss. 6, 2012-07 ,pp. : 746-758

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Pathogenesis of Alzheimer's Disease: An Update

By  

Annals of Neurosciences, Vol. 24, Iss. 1, 2017-04 ,pp. : 46-54

Karger

Access to resources Recommend Favorite

Genomic and Molecular Characterization of Alzheimer Disease

By  

Current Psychiatry Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 104-113

Bentham Science Publishers

Access to resources Recommend Favorite